Home LiteratureArticle Details
PMID: 4022696 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S.

Gastrointestinal injury in polycythemic term infants.

Pediatrics ·Vol. 76 ·No. 2 ·1985-08-00 ·Pages 225-31

Black VD, Rumack CM, Lubchenco LO, Koops BL

Abstract

Necrotizing enterocolitis is uncommon among term infants. In this group, necrotizing enterocolitis has been associated with two risk factors: polycythemia and umbilical catheterization. During a randomized trial of partial plasma exchange transfusion for treatment of polycythemia, an increased risk of gastrointestinal problems was noted. Eight hyperviscous patients treated with partial plasma exchange transfusion, no symptomatically treated patients, and no control infants developed typical necrotizing enterocolitis (blood in the stools, pneumatosis, and systemic signs). The incidence of necrotizing enterocolitis was significantly greater among patients treated with exchange transfusion compared with patients treated symptomatically or control subjects (P less than .001).

MeSH Terms
Blood Viscosity Enterocolitis, Pseudomembranous/etiology Hematocrit Humans Infant, Newborn Plasma Exchange Pneumatosis Cystoides Intestinalis/etiology Polycythemia/complications,therapy Risk
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Black V D
Rumack C M
Lubchenco L O
Koops B L
Article Info
Journal
Pediatrics
Abbr.
Pediatrics
ISSN
0031-4005
Published
1985-08-00
Pages
225-31
Language
English
Region
United States
NLM ID
0376422
Subset
IM
Grants
PHS HHS · C229057 · United States
PHS HHS · C291034 · United States
NCRR NIH HHS · RR-69 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]